| Matrin-3 Protein | |
|---|---|
| Gene | [MATR3](/genes/matr3) |
| UniProt | P43243 |
| PDB | 5D99 |
| Mol. Weight | 125 kDa |
| Localization | Nuclear matrix, speckles |
| Family | Matrin-3 family, RNA-binding |
| Diseases | [ALS](/diseases/als), [FTD](/diseases/ftd), [Parkinson's Disease](/diseases/parkinsons-disease) |
Matrin 3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Matrin-3 is a nuclear matrix protein with dual roles as an RNA-binding protein and DNA-binding transcription factor[1]. Mutations in MATR3 are causally linked to familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), establishing it as an important disease protein in neurodegeneration[2].
The MATR3 gene encodes a protein of approximately 847 amino acids that is ubiquitously expressed but with highest levels in skeletal muscle and neuronal tissues. Matrin-3 is a core component of the nuclear matrix, the structural framework that organizes the nucleus[3].
Matrin-3 contains multiple functional domains:
Two RNA recognition motifs (RRM1 and RRM2) in the central region mediate RNA binding. These domains are highly conserved and recognize specific RNA sequences.
Multiple C2H2-type zinc-finger domains in the C-terminal region mediate DNA binding and protein-protein interactions.
NLS sequences direct Matrin-3 to the nuclear compartment.
A glycine-rich domain facilitates protein-protein interactions[4].
Matrin-3 is a principal component of the nuclear matrix:
As an RNA-binding protein, Matrin-3 participates in:
Matrin-3 functions as a transcriptional co-regulator:
Dominant mutations in MATR3 cause familial ALS, typically with a late onset and predominantly upper motor neuron involvement. Notable mutations include:
The pathogenic mechanisms include:
MATR3 mutations also cause FTD, often with overlapping clinical features with ALS. TDP-43 pathology is commonly observed in MATR3-associated FTD[^7].
Matrin-3 interacts with proteins implicated in PD pathogenesis, including:
Dysregulation of Matrin-3 function may contribute to dopaminergic neuron vulnerability[^8].
Current therapeutic approaches include:
The study of Matrin 3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Johnson et al. Mutations in MATR3 cause ALS (2014). 2014. ↩︎
Giordano et al. Matrin-3 in RNA processing (2013). 2013. ↩︎
Zhang et al. Matrin-3 and TDP-43 pathology (2019). 2019. ↩︎
Tao et al. Matrin-3 in nuclear organization (2020). 2020. ↩︎